pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-5p | |||||||||||||||||||||||||||
Sequence | 23| AUGCUGACAUAUUUACUAGAGG |44 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MAOB | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | monoamine oxidase B | ||||||||||||||||||||
Transcript | NM_000898 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MAOB | |||||||||||||||||||||
3'UTR of MAOB (miRNA target sites are highlighted) |
>MAOB|NM_000898|3'UTR 1 AGAGAGAGGGTGTCTGTAATCACACTCTCTTCTTACTGTATTTGGGATATGAGTTTGGGGAAAGAGTTGCAGTAAAGTTC 81 CATGAAGACAAATAGTGTGGAGTGAGGCGGGGAGCATGAAGATAAATCCAACTCTGACTGTAAAATACATGGTATCTCTT 161 TCTCCGTTGTGGCCCCTGCTTAGTGTCCCTTACCTGGCTTAGCGTTCTGTTTCACCAGTTTCCAAGTTTATTGCCCTCAA 241 AATCTTTAGAATAGTTAAATTGGCTTGTTTAAGGTTCTTGCTGCCCCACAACACACCTTGCCCATGCACAAGGAATGAAT 321 TTTTTCCTACCATTATGGCTTTGTGCTTGTTCTTCCTCTTACCTGTAATAGCCTCACCTTCCCTAGTTCTTTGCATTCGT 401 CCTTAGAATACTGTATTGTTACAGCTGAAAGACAGTAAAGACCATTTAGTCCTCACCTTCTGTTTTAGAGTTGAGCAAAC 481 TGAAGCCCACAGAGGTGGAACTTAATTACCTAAGAGCCACAATAAGCCACTGGTATCTGGGGGACTAGAACACAAATCCA 561 ACGCTTTTCCCACCTCTTTGGATGTTTTCCCCAATTATCCTCCTTCACTCCCTGTCATAGTTACCGATGGTGTCCCGTTG 641 TGTGGGTTTACTCTGTGCTAAGTTGTCTTACACTTCTCAAATGCTACTCAGTATATAGCCTTAAGTCTTACTGTTTTGTG 721 CGGTGTGTCTCCAGCTGATTTTAACTTTTTTGATGGTAGAAATTTTATCTCTTCTTCCTTTTGTATCCTCCATTGTATCT 801 TCATACAAAGGACAGTACACACTTGGGTAATTAAAAATAAAAGTTGATTGACCATAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 4129.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000538942.1 | 3UTR | ucuuuucagcaacggcucuug |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
44 hsa-miR-628-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT037783 | NELFE | negative elongation factor complex member E | 1 | 1 | ||||||||
MIRT200944 | ZNF264 | zinc finger protein 264 | 2 | 6 | ||||||||
MIRT441916 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT443436 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT443447 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT443906 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT449750 | SMYD2 | SET and MYND domain containing 2 | 2 | 2 | ||||||||
MIRT461377 | SLFN12L | schlafen family member 12 like | 2 | 2 | ||||||||
MIRT466416 | TFAP2A | transcription factor AP-2 alpha | 2 | 8 | ||||||||
MIRT486594 | CTPS2 | CTP synthase 2 | 2 | 2 | ||||||||
MIRT491945 | VPS52 | VPS52, GARP complex subunit | 2 | 2 | ||||||||
MIRT513492 | SSR1 | signal sequence receptor subunit 1 | 2 | 6 | ||||||||
MIRT528599 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT531325 | SEMA3D | semaphorin 3D | 2 | 2 | ||||||||
MIRT532082 | RTTN | rotatin | 2 | 2 | ||||||||
MIRT532563 | CSTF1 | cleavage stimulation factor subunit 1 | 2 | 2 | ||||||||
MIRT532976 | ZNF12 | zinc finger protein 12 | 2 | 2 | ||||||||
MIRT534075 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 2 | ||||||||
MIRT536103 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT536183 | MAOB | monoamine oxidase B | 2 | 2 | ||||||||
MIRT543755 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT550000 | KIAA0408 | KIAA0408 | 2 | 2 | ||||||||
MIRT551237 | COLEC10 | collectin subfamily member 10 | 2 | 2 | ||||||||
MIRT567554 | FEN1 | flap structure-specific endonuclease 1 | 2 | 2 | ||||||||
MIRT570387 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | 2 | 2 | ||||||||
MIRT570808 | LYN | LYN proto-oncogene, Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT576346 | Pxdn | peroxidasin | 2 | 2 | ||||||||
MIRT576520 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT576893 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT606796 | BICD2 | BICD cargo adaptor 2 | 2 | 2 | ||||||||
MIRT625909 | GBP6 | guanylate binding protein family member 6 | 2 | 2 | ||||||||
MIRT626869 | PDGFRA | platelet derived growth factor receptor alpha | 2 | 2 | ||||||||
MIRT643603 | IRAK4 | interleukin 1 receptor associated kinase 4 | 2 | 2 | ||||||||
MIRT645451 | FOXE1 | forkhead box E1 | 2 | 2 | ||||||||
MIRT652265 | TOMM20 | translocase of outer mitochondrial membrane 20 | 2 | 2 | ||||||||
MIRT689023 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT691057 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT704712 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT713069 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT719483 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT732944 | AGAP2-AS1 | AGAP2 antisense RNA 1 | 3 | 0 | ||||||||
MIRT732945 | KLF12 | Kruppel like factor 12 | 3 | 0 | ||||||||
MIRT733520 | BMP2 | bone morphogenetic protein 2 | 3 | 0 | ||||||||
MIRT733521 | ETV1 | ETS variant 1 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|